Are mast cells MASTers in HIV-1 infection?

International Archives of Allergy and Immunology

Volumn 125, Issue 2, 2001, Pages 89-95

  Marone, Gianni ^a   De Paulis, Amato ^a   Florio, Giovanni ^a   Petraroli, Angelica ^a   Rossi, Francesca W ^a   Triggiani, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

AIDS; Basophils; CCR3; Chemokine; HIV 1; IL 13; IL 4; Mast cells; Tat

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; TRANSACTIVATOR PROTEIN;

BASOPHIL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAST CELL; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR UPREGULATION; REVIEW;

BASOPHILS; CHEMOTAXIS; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; HISTAMINE RELEASE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-13; INTERLEUKIN-4; MACROMOLECULAR SUBSTANCES; MAST CELLS; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; RECEPTORS, IGE; SUPERANTIGENS; TH1 CELLS; TH2 CELLS; VIRUS REPLICATION;

EID: 0034939692     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053802     Document Type: Review

References (84)

1. Asthma: Recent advances
2. H3 region of IgE
3. H3 region of IgE
4. Human synovial mast cells. I. Ultrastructure in situ and in vitro immunologic characterization
5. Stem cell factor is localized in, released from, and cleaved by human mast cells
6. Role for IL-3 in mast cell and basophil development and in immunity to parasites
7. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α
8. Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E
9. Protein Fv produced during viral hepatitis is a novel activator of human basophils and mast cells
10. The AIDS epidemic - Considerations for the 21st century
11. Host factors and the pathogenesis of HIV-induced disease
12. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals
13. A TH1→TH2 switch is a critical step in the etiology of HIV infection
14. H2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients
15. + T-cell clones in human immunodeficiency virus infection
16. Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection
17. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry
18. Increased T-helper-type 2 cytokine production in chronic HIV infection is due to interleukin (IL)-13 rather than IL-4
19. In vivo alteration in type-1 and type-2 cytokine balance: A possible mechanism for elevated total IgE in HIV-infected patients
20. Elevation of IgE in HIV-infected children and its correlation with the progression of disease
21. Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progression
22. Serum total and specific IgE levels in children infected with human immunodeficiency virus
23. IgE against HIV proteins in clinically healthy children with HIV disease
24. Objective measures of allergic disease in children with human immunodeficiency virus infection
25. Eosinophil involvement and serum IgE level in HIV-1-infected children
26. + T-cells
27. Serum IgE and human immunodeficiency virus (HIV) infection
28. Immunoglobulin E levels in relationship to HIV-1 disease, route of infection, and vitamin E status
29. Elevated IgE level in relationship to nutritional status and immune parameters in early human immunodeficiency virus-1 disease
30. Immunologic aspects of hyperimmunoglobulinemia E-like syndrome in patients with AIDS
31. IgE serum level: A prognostic marker for AIDS in HIV-infected adults?
32. Pneumocystis cariniipneumonia: A comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies
33. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS)
34. Cutaneous disease and drug reactions in HIV infection
35. HIV antigen-induced release of histamine from basophils from HIV infected patients. Mechanism and relation to disease progression and immunodeficiency
36. The immunoglobulin superantigen-binding site of HIV-1 gp120 activates human basophils
37. H2 predominance in HIV-infected individuals
38. H0 cells
39. HIV infection alters the production of both type 1 and 2 cytokines but does not induce a polarized type 1 or 2 state
40. Elevation of IgE in HIV-infected subjects: A marker of poor prognosis
41. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus
42. Hyper-IgE and human immunodeficiency virus infection
43. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants
44. Interleukin-13: Central mediator of allergic asthma
45. Requirement for IL-13 independently of IL-4 in experimental asthma
46. Induction of human IgE synthesis in B cells by mast cells and basophils
47. IL-4 secretion and histamine release by human basophils are differentially regulated by protein kinase C activation
48. Frequency and characterization of antigen-specific IL-4- and IL-13-producing basophils and T cells in peripheral blood of healthy and asthmatic subjects
49. Interleukin 4 is localized to and released by human mast cells
50. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells
51. Activated mast cells produce interleukin 13
52. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcεRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells
53. Coreceptors: Implications for HIV pathogenesis and therapy
54. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
55. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines
56. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines
57. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro
58. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
59. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
60. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
61. Role of the β-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia
62. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
63. B-cell superantigens
64. Identification of the B cell superantigen-binding site of HIV-1 gp120
65. Structural basis of the gp120 superantigen-binding site on human immunoglobulins
66. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins
67. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13
68. Enhanced HIV expression during Th2-oriented responses explained by the opposite regulatory effect of IL-4 and IFN-γ on fusin/CXCR4
69. + T cell depletion in HIV-1-infected human lymphoid tissue
70. Regulation of HIV-1 gene expression by the transactivator protein Tat
71. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
72. Transcellular transactivation by the human immunodeficiency virus type 1 tat protein
73. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120
74. Cellular uptake of the tat protein from human immunodeficiency virus
75. + cells
76. Identification of a novel population of mast cells/basophils in human peripheral blood of allergic patients which is HIV-1 susceptible due to its surface expression of CD4, CCR5, and CXCR4
77. Spectrum of morphologic changes of lymph nodes in HIV infection
78. Mast cells in the brain: Evidence and functional significance
79. The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand SDF-1α acts as a mast cell chemotaxin
80. Chemokine stromal cell-derived factor 1α activates basophils by means of CXCR4